Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Jan Jacques Michiels"'
Autor:
Inge Vangenechten, Petr Smejkal, Jiri Zavrelova, Ondrej Zapletal, Alexander Wild, Jan Jacques Michiels, Zwi Berneman, Jan Blatny, Angelika Batorova, Tatiana Prigancova, Miroslav Penka, Alain Gadisseur
Publikováno v:
TH Open, Vol 06, Iss 04, Pp e335-e346 (2022)
Background von Willebrand disease (VWD) is a genetic bleeding disorder caused by defects of von Willebrand factor (VWF), quantitative (type 1 and 3) or qualitative (type 2). The laboratory phenotyping is heterogenic making diagnosis difficult. Object
Externí odkaz:
https://doaj.org/article/75dd3755ee8443b3a845469109e1de0d
Autor:
Jan Jacques Michiels, Hendrik De Raeve, Francisca Valster, Vincent Potters, Yonggoo Kim, Myungshin Kim
Publikováno v:
European Medical Journal, Vol 2, Iss 2, Pp 72-81 (2017)
Improved Clinical, Laboratory, Molecular, and Pathological (CLMP) 2017 criteria for myeloproliferative neoplasms (MPN) define the JAK2V617F trilinear MPNs as a broad continuum of essential thrombocythaemia (ET), polycythaemia vera (PV), masked PV, an
Externí odkaz:
https://doaj.org/article/5e22444b17c845d3bee2e3d9dbc630a4
Autor:
Jan Jacques Michiels, Fibo Ten Kate, King H. Lam, Wilfried Schroyens, Zwi Berneman, Hendrik De Raeve
Publikováno v:
Turkish Journal of Hematology, Vol 31, Iss 3, Pp 239-254 (2014)
OBJECTIVE: The prefibrotic stages of JAK2V617F essential thrombocythemia (ET) and JAK2V617F polycythemia vera (PV) can easily be diagnosed clinically without use of bone marrow biopsy histology. We assessed the 2008 WHO and European Clinical, Molecul
Externí odkaz:
https://doaj.org/article/8181e14111e84bf1bbe0d9c8d49c9f6b
Autor:
Jan Jacques Michiels, Goodheart Institute & Foundation, Freedom Of Science And Education Thrombocythemia Vera Study Group, Tvsg And European Working Groups On Myeloproliferative Neoplasms: Ewg.mpn
Publikováno v:
Turkish Journal of Hematology, Vol 30, Iss 2, Pp 102-110 (2013)
According to Dameshek, true polycythemia (polycythemia vera: PV) is a chronic myeloproliferative disorder of the total bone marrow without any evidence of invasiveness, in which erythrocytosis, leukocytosis, and thrombocytosis are all simultaneously
Externí odkaz:
https://doaj.org/article/9fb10f4236fd4ba4bfe228f8c97e4853
Autor:
Tereza Fidalgo, Ulrich Budde, Tatiana Prigancova, Jan Jacques Michiels, Angelika Batorova, Inge Vangenechten, Miroslav Penka, Francisco Javier Battle, Alain Gadisseur, D. Flemming Hansen, Petr Smejkal, Jan Blatny
Publikováno v:
Acta Scientific Medical Sciences. 3:140-158
The FVIII binding site on von Willebrand factor (VWF) is located in the D’ (766-864) and D3 (1054-1060) regions of the VWF gene. The cysteine residues in the D’ domain form disulfide bridges within the D’ trypsin-inhibitor-like (TIL’) and E
Autor:
Inge Vangenechten, Jan Jacques Michiels, Ondrej Zapletal, Petr Smejkal, Miroslav Penka, Jiri Zavrelova, Zwi N. Berneman, Alain Gadisseur, Jan Blatný
Publikováno v:
Thrombosis and haemostasis : international journal for vascular biology and medicine
Background von Willebrand disease (VWD) is an inherited bleeding disorder caused by a quantitative (type 1 and 3) or qualitative (type 2) defect of von Willebrand factor (VWF). The heterogeneity of laboratory phenotyping makes diagnosing difficult. O
Autor:
Jan Jacques Michiels, Craig M. Kessler
Thrombocytosis from excessive platelet counts is most commonly discovered on routine blood counts in asymptomatic patients. Most elevations are “reactive” due to enhanced physiological production of platelets from normal yet stimulated bone marro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e893fbb2d9d5907ee9f2d66ed9704998
https://doi.org/10.1016/b978-0-323-46202-0.00019-4
https://doi.org/10.1016/b978-0-323-46202-0.00019-4
Autor:
Jan Jacques Michiels, Petr Smejkal, Ulrich Budde, Alain Gadisseur, Tatiana Pricangova, Inge Vangenechten, Angelika Batorova, Miroslav Penka
Publikováno v:
Clinical and applied thrombosis/hemostasis
The European Clinical Laboratory and Molecular (ECLM) classification of von Willebrand disease (vWD) is based on the splitting approach which uses sensitive and specific von Willebrand factor (vWF) assays with regard to the updated molecular data on
Autor:
Alain Gadiseur, Wilfried Schroyens, Wim Moossdorff, Mildred Lao, Jan Jacques Michiels, Hanny Maasland
Publikováno v:
Angiology: the journal of vascular diseases
Of 1330 outpatients with suspected deep vein thrombosis (DVT), a normal enzyme-linked immunosorbent assay (ELISA) d-dimer (VIDAS) of
Autor:
Janneke Maria Michiels, Hans Smeets, Benilde Cosmi, Hanny Maasland, Jan Jacques Michiels, Ming Han, Karel Roztocil, Zsolt Pecsvarady, Wim Moossdorff, Pier Luigi, Mildred Lao, Viera Štvrtinová, Petr Dulíček, Ludovit Gaspar
Publikováno v:
Family Medicine & Medical Science Research.
Background: Two point CUS (2-CUS) for the diagnosis of symptomatic proximal DVT overlooks calf vein thrombosis (CVT) indicating the need to repeat 2-CUS after one week, which is not cost-effective. Complete CUS (CCUS) of all deep veins from the groin